Koppers (KOP) came out with quarterly earnings of $0.7 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.98%. A quarter ago, it was expected that this maker of chemicals, carbon compounds and wood treatment products would post earnings of $1.25 per share when it actually produced earnings of $1.21, delivering a surprise of ...

Core Viewpoint - LyondellBasell reported a quarterly loss of $0.26 per share, missing the Zacks Consensus Estimate of $0.18, and a significant decline from earnings of $0.75 per share a year ago, indicating an earnings surprise of -244.44% [1] Financial Performance - The company posted revenues of $7.09 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.53%, but down from $9.5 billion in the same quarter last year [2] - Over the last four quarters, LyondellBasell has exceeded consensus revenue estimates four times, but has only surpassed consensus EPS estimates once [2] Stock Performance - LyondellBasell shares have increased by approximately 15.4% since the beginning of the year, outperforming the S&P 500's gain of 1.8% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.67 on revenues of $7.56 billion, and for the current fiscal year, it is $3.46 on revenues of $29.74 billion [7] - The estimate revisions trend for LyondellBasell was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Chemical - Diversified industry, to which LyondellBasell belongs, is currently ranked in the bottom 14% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8]

Core Viewpoint - LyondellBasell (LYB) shares experienced a significant increase of 6.8% to $52, driven by rising oil prices and concerns over supply disruptions in Iran, enhancing the company's competitive cost advantage [1]. Group 1: Stock Performance - LYB's stock has gained 13.2% over the past four weeks, indicating a positive trend in its market performance [1]. - The stock's recent rally occurred with a higher-than-average trading volume, suggesting strong investor interest [1]. Group 2: Earnings Expectations - LyondellBasell is projected to report quarterly earnings of $0.13 per share, reflecting a substantial year-over-year decline of 82.7% [2]. - Revenue expectations for the upcoming quarter are set at $6.98 billion, which is a decrease of 26.5% compared to the same quarter last year [2]. Group 3: Earnings Estimate Revisions - The consensus EPS estimate for LyondellBasell has been revised down by 6.2% over the last 30 days, indicating a negative trend in earnings estimate revisions [3]. - Historically, a negative trend in earnings estimate revisions is associated with limited price appreciation potential [3]. Group 4: Industry Context - LyondellBasell holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook compared to other stocks in the market [4]. - The company is part of the Zacks Chemical - Diversified industry, which includes other stocks like Tronox (TROX), which has shown a 25.9% return over the past month [4].

Core Viewpoint - Investors in LSB Industries, Inc. (LXU) should closely monitor the stock due to significant movements in the options market, particularly the Mar 20, 2026 $17.50 Put, which has shown high implied volatility [1] Group 1: Implied Volatility - Implied volatility indicates the market's expectations for future stock movement, with high levels suggesting anticipation of a significant price change or an upcoming event that could trigger a rally or sell-off [2] - Options traders often seek high implied volatility options to sell premium, aiming to benefit from the decay of options value if the stock does not move as expected [4] Group 2: Analyst Insights - LSB Industries holds a Zacks Rank 1 (Strong Buy) in the Chemical - Diversified industry, which is positioned in the bottom 11% of the Zacks Industry Rank [3] - Over the past 60 days, one analyst has raised the earnings estimate for the current quarter, increasing the Zacks Consensus Estimate from 9 cents per share to 18 cents, with no downward revisions from other analysts [3]

Core Insights - Albemarle's shares have increased by approximately 30.6% since the last earnings report, outperforming the S&P 500 [1] Financial Performance - In Q3 2025, Albemarle reported adjusted losses of 19 cents per share, a significant improvement from losses of $1.55 per share a year ago, and better than the Zacks Consensus Estimate of a loss of 92 cents [2] - Revenues decreased by about 3.5% year over year to $1,307.8 million, surpassing the Zacks Consensus Estimate of $1,292 million, impacted by lower prices in the Energy Storage segment but offset by volume growth in Energy Storage and Ketjen [3] - Adjusted EBITDA for the quarter was $225.6 million, an increase from $211.5 million in the prior-year quarter, driven by lower input costs and cost reduction efforts [3] Segment Highlights - The Energy Storage unit's sales fell around 7.6% year over year to $708.8 million, exceeding the consensus estimate of $678 million, with an 8% increase in sales volumes due to higher spodumene sales and record production [4] - The Specialties segment recorded sales of $345 million, up approximately 0.8% year over year but below the consensus estimate of $349 million, with foreign exchange benefits offsetting lower volume [5] - The Ketjen unit achieved revenues of $254.1 million, up roughly 3.7% year over year, beating the consensus estimate of $248 million, although higher volumes were partially offset by lower prices [5] Financial Position - Albemarle ended the quarter with cash and cash equivalents of approximately $1,931.8 million, an increase from $1,664.5 million in the prior-year quarter, while long-term debt rose to around $3,181 million, up about 2% sequentially [6] - Cash from operations for the first nine months of 2025 was around $893.8 million, reflecting a 29% increase from the prior-year period [6] 2025 Outlook - The company has raised its full-year outlook for the enterprise and Energy Storage, expecting results to be near the higher end of the earlier $9/kg forecast range due to strong performance and higher lithium prices [7] - Capital expenditures for full-year 2025 are expected to be roughly $600 million, with depreciation and amortization expenses projected between $630-$670 million [8] Estimate Trends - Consensus estimates have trended downward over the past month, with a shift of -11.71% noted [9] - Albemarle currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return from the stock in the coming months [11] Industry Performance - Albemarle is part of the Zacks Chemical - Diversified industry, where Dow Inc. has gained 2.9% over the past month, reporting revenues of $9.97 billion for the quarter ended September 2025, reflecting a year-over-year change of -8.3% [12]

Core Insights - LyondellBasell (LYB) reported quarterly earnings of $1.01 per share, exceeding the Zacks Consensus Estimate of $0.80 per share, but down from $1.88 per share a year ago, indicating an earnings surprise of +26.25% [1] - The company generated revenues of $7.73 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.11%, but down from $10.32 billion year-over-year [2] - LyondellBasell's shares have declined approximately 39.1% year-to-date, contrasting with the S&P 500's gain of 16% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.57 on revenues of $7.02 billion, and for the current fiscal year, it is $2.34 on revenues of $29.85 billion [7] Industry Context - The Chemical - Diversified industry, to which LyondellBasell belongs, is currently ranked in the bottom 8% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact LyondellBasell's stock performance [5]

Company Performance - LSB reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of $0.07 per share, compared to a loss of $0.11 per share a year ago, representing an earnings surprise of +42.86% [1] - The company posted revenues of $155.43 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 30.26%, and compared to year-ago revenues of $109.22 million [2] - Over the last four quarters, LSB has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - LSB shares have increased approximately 21.2% since the beginning of the year, outperforming the S&P 500's gain of 17.2% [3] - The current consensus EPS estimate for the coming quarter is $0.09 on $123.65 million in revenues, and $0.22 on $537.7 million in revenues for the current fiscal year [7] Industry Outlook - The Zacks Industry Rank indicates that the Chemical - Diversified sector is currently in the bottom 7% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact LSB's stock performance [5]

Group 1 - LSB (LXU) shares experienced a significant increase of 12.4%, closing at $8.99, following a period of 2.4% loss over the past four weeks, indicating a strong trading session with higher-than-average volume [1] - The company's positive outlook is driven by strong selling prices and favorable demand, alongside steady exports and lower imports, resulting in tight supply fundamentals in the ammonia market [2] - LSB is projected to report quarterly earnings of $0.05 per share, reflecting a year-over-year increase of 145.5%, with expected revenues of $119.32 million, up 9.3% from the previous year [3] Group 2 - The consensus EPS estimate for LSB has remained unchanged over the last 30 days, suggesting that the stock's price movement may not sustain without trends in earnings estimate revisions [4] - LSB holds a Zacks Rank of 3 (Hold), indicating a neutral outlook within the Zacks Chemical - Diversified industry, where DuPont de Nemours (DD) also holds a Zacks Rank of 3 [5] - DuPont de Nemours has seen a slight decrease in its consensus EPS estimate by 0.2% over the past month, now projected at $1.13, which is a 4.2% decline from the previous year [6]

Core Viewpoint - Methanex's recent earnings report shows a mixed performance with increased profits but declining revenues, raising questions about future trends leading up to the next earnings release [1][2]. Financial Performance - The second-quarter profit attributable to shareholders was $64 million or 93 cents per share, an increase from $35 million or 52 cents per share in the same quarter last year [2]. - Adjusted earnings per share were 97 cents, exceeding the Zacks Consensus Estimate of 42 cents [2]. - Revenues fell approximately 13.4% year over year to $797 million, missing the Zacks Consensus Estimate of $873.9 million [3]. - Adjusted EBITDA rose around 11.6% year over year to $183 million [3]. Operational Highlights - Production totaled 1,621,000 tons, up 14% year over year, with increased output from Geismar and Trinidad, offset by reduced production from Egypt, Canada, Chile, and New Zealand [4]. - Total sales volume in the first quarter was 2,133,000 tons, down 18.3% year over year, missing the estimate of 2,387,000 tons [5]. - The average realized price for methanol was $374 per ton, up from $352 per ton in the prior-year quarter, exceeding the estimate of $362 per ton [5]. Financial Position - Cash and cash equivalents were $485 million at the end of the quarter, with cash flow from operating activities at $277 million [6]. - The company returned $12.5 million to shareholders through dividends in the reported quarter [6]. Future Outlook - Methanex expects its 2025 production to be approximately 8 million tons, subject to fluctuations due to gas availability and maintenance [7]. - The company anticipates higher adjusted EBITDA in the third quarter of 2025 compared to the second quarter, driven by increased sales volume, although the average realized price is expected to decrease to between $335 and $345 per ton [8]. Market Sentiment - Estimates for Methanex have trended downward over the past month, with a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [9][11]. - Methanex has a strong Growth Score of A but lags in Momentum with a C, while maintaining an overall VGM Score of A, placing it in the top quintile for value investors [10]. Industry Comparison - Methanex is part of the Zacks Chemical - Diversified industry, where competitor Olin has gained 20.7% over the past month, reporting revenues of $1.76 billion with a year-over-year change of +7% [12]. - Olin's expected earnings for the current quarter are $0.15 per share, reflecting a year-over-year change of +171.4% [13].

Core Viewpoint - Albemarle's recent earnings report shows a mixed performance with adjusted earnings surpassing estimates, but revenues declining year over year, raising questions about future trends leading up to the next earnings release [1][2][3]. Financial Performance - Adjusted earnings for Q2 2025 were 11 cents per share, compared to 4 cents per share a year ago, beating the Zacks Consensus Estimate of a loss of 83 cents [2]. - Revenues fell approximately 7% year over year to around $1.33 billion, exceeding the Zacks Consensus Estimate of $1.24 billion, primarily due to lower prices in the Energy Storage segment [3]. - Adjusted EBITDA for the quarter was $336.5 million, down from $386.4 million in the prior-year quarter, as a decline in lithium pricing offset cost reduction efforts [4]. Segment Highlights - The Energy Storage unit's sales decreased about 13.5% year over year to $717.7 million, surpassing the consensus estimate of $589.4 million, with sales volumes up 15% [5]. - The Specialties segment recorded sales of $351.6 million, up around 5.1% year over year, exceeding the consensus estimate of $344.7 million, driven by increased volumes [6]. - The Ketjen unit's revenues were $260.8 million, down roughly 1.8% year over year, slightly beating the consensus estimate of $260 million [6]. Financial Position - Albemarle ended the quarter with cash and cash equivalents of approximately $1.81 billion, an increase from $1.52 billion in the prior quarter, while long-term debt rose to around $3.18 billion [7]. - Cash from operations for the first half of 2025 was around $538 million, reflecting a 15.7% increase from the prior-year period [7]. 2025 Outlook - The company is implementing measures to enhance costs, productivity, and efficiencies, anticipating growth in volumes in key end markets within the Specialties unit [8]. - Capital expenditures for the full year 2025 are expected to be in the range of $650-$700 million [8]. - Depreciation and amortization expenses are projected to be $630-$670 million, with corporate costs estimated at $40-$70 million and interest and financing expenses forecasted at $180-$210 million for the full year [9]. Estimate Trends - Consensus estimates have trended downward over the past month, with a significant shift of -60.13% noted [10]. - Albemarle currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return from the stock in the upcoming months [12]. Industry Comparison - Albemarle operates within the Zacks Chemical - Diversified industry, where Dow Inc. has seen a 5.5% gain over the past month, despite reporting a year-over-year revenue decline of 7.4% [13]. - Dow Inc. is expected to post a loss of $0.26 per share for the current quarter, reflecting a change of -155.3% from the previous year, with a Zacks Rank 5 (Strong Sell) [14].